Lista de obras - Alan Whone - Dominio Público Uruguay

A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.

artículo científico publicado en 2004

Basal ganglia necrosis: a 'best-fit' approach

artículo científico publicado en 2016

Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life.

artículo científico publicado en 2011

Cerebral ischaemia in the context of improving, steroid-treated pneumococcal meningitis

artículo científico publicado en 2011

Clinical outcomes from bilateral versus unilateral stimulation of the pedunculopontine nucleus with and without concomitant caudal zona incerta region stimulation in Parkinson's disease.

artículo científico publicado en 2012

Combined pedunculopontine-subthalamic stimulation in Parkinson disease.

artículo científico publicado en 2012

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease

artículo científico publicado en 2016

Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

artículo científico publicado en 2016

Deep brain stimulation: practical insights and common queries

artículo científico publicado en 2019

Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making

artículo científico publicado en 2012

Dopamine and Consolidation of Episodic Memory: Timing is Everything.

artículo científico publicado en 2015

Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease

artículo científico publicado en 2017

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease

scientific article published on 01 January 2019

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

artículo científico publicado en 2007

Freezing of Gait in People with Parkinson's Disease: Nature, Occurrence, and Risk Factors

artículo científico publicado en 2020

Functional brain imaging in the differential diagnosis of Parkinson's disease

artículo científico publicado en 2004

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor.

artículo científico publicado en 2011

Implementing novel trial methods to evaluate surgery for essential tremor.

artículo científico publicado en 2015

Letter to the editor on "Evidence for dopaminergic denervation in classical galactosemia".

artículo científico publicado en 2017

Mesenchymal stem cells and neurodegenerative disease

scientific article published on 01 January 2009

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

artículo científico publicado en 2003

Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.

artículo científico publicado en 2015

Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study

artículo científico publicado en 2004

Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.

artículo científico publicado en 2011

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

scientific journal article

Plasticity of the nigropallidal pathway in Parkinson's disease.

artículo científico publicado en 2003

Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.

artículo científico publicado en 2011

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease

artículo científico publicado en 2019

Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation.

artículo científico publicado en 2014

Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation

artículo científico publicado en 2014

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.

artículo científico publicado en 2014

SGCE mutations cause psychiatric disorders: clinical and genetic characterization

artículo científico publicado en 2013

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

artículo científico publicado en 2010

Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

scientific article published on 07 October 2019

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease

artículo científico publicado en 2018

Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson's Disease in the Home or a Home-like Environment

artículo científico publicado en 2020

Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells ⬇️

artículo científico publicado el 1 de enero de 2001

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen

artículo científico publicado en 2013

Tracking Parkinson's: Study Design and Baseline Patient Data

artículo científico publicado en 2015

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease ⬇️

artículo científico publicado el 27 de febrero de 2013

Lista de obras de Alan Whone

A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.

Basal ganglia necrosis: a 'best-fit' approach

Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life.

Cerebral ischaemia in the context of improving, steroid-treated pneumococcal meningitis

Clinical outcomes from bilateral versus unilateral stimulation of the pedunculopontine nucleus with and without concomitant caudal zona incerta region stimulation in Parkinson's disease.

Combined pedunculopontine-subthalamic stimulation in Parkinson disease.

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease

Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

Deep brain stimulation: practical insights and common queries

Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making

Dopamine and Consolidation of Episodic Memory: Timing is Everything.

Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease

Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

Freezing of Gait in People with Parkinson's Disease: Nature, Occurrence, and Risk Factors

Functional brain imaging in the differential diagnosis of Parkinson's disease

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor.

Implementing novel trial methods to evaluate surgery for essential tremor.

Letter to the editor on "Evidence for dopaminergic denervation in classical galactosemia".

Mesenchymal stem cells and neurodegenerative disease

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.

Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study

Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

Plasticity of the nigropallidal pathway in Parkinson's disease.

Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease

Retromer Binding to FAM21 and the WASH Complex Is Perturbed by the Parkinson Disease-Linked VPS35(D620N) Mutation.

Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation

Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial

SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.

SGCE mutations cause psychiatric disorders: clinical and genetic characterization

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease

Systematic Review Looking at the Use of Technology to Measure Free-Living Symptom and Activity Outcomes in Parkinson's Disease in the Home or a Home-like Environment

Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells ⬇️

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen

Tracking Parkinson's: Study Design and Baseline Patient Data

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease ⬇️